| 1 |
32089236 | Fungal polysaccharides. | 2020 |
1 |
| 2 |
22158618 | Lectin site ligation of CR3 induces conformational changes and signaling. | 2012 Jan 27 |
3 |
| 3 |
19515245 | The effects of beta-glucan on human immune and cancer cells. | 2009 Jun 10 |
1 |
| 4 |
15027124 | Beta-glucan enhanced killing of renal cell carcinoma micrometastases by monoclonal antibody G250 directed complement activation. | 2004 May 10 |
1 |
| 5 |
14532278 | Release of arachidonic acid by stimulation of opsonic receptors in human monocytes: the FcgammaR and the complement receptor 3 pathways. | 2003 Dec 26 |
1 |
| 6 |
12018461 | Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion. | 2002 |
2 |
| 7 |
12384807 | Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies. | 2002 Nov |
1 |
| 8 |
9933447 | Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules. | 1999 Feb |
2 |
| 9 |
9973505 | The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. | 1999 Feb 15 |
3 |
| 10 |
10408367 | Therapeutic intervention with complement and beta-glucan in cancer. | 1999 May |
1 |
| 11 |
9844058 | A mixed population of immature and mature leucocytes in umbilical cord blood results in a reduced expression and function of CR3 (CD11b/CD18). | 1998 Dec |
2 |
| 12 |
8100571 | CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents. | 1993 May |
1 |
| 13 |
8485905 | CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. | 1993 May |
1 |
| 14 |
2060581 | The function of human NK cells is enhanced by beta-glucan, a ligand of CR3 (CD11b/CD18). | 1991 Jul |
3 |
| 15 |
3040332 | Specificity of membrane complement receptor type three (CR3) for beta-glucans. | 1987 |
7 |